India Glycols shares fall 1.39% as second-quarter profit drops to 11.24 crore rupees
Key Facts
India Glycols shares fell 1.39% to 270.20 rupees at 13:24 India time on November 18, 2026, while standalone results for the second quarter of FY27 showed profit after tax declining to 11.24 crore rupees from 53.94 crore a year earlier. The company announced unaudited results for the quarter ended September 30, 2026, saying they covered continuing operations after the reorganisation. Operating revenue fell to 358.18 crore rupees from 2,410.71 crore in the year-earlier quarter, while earnings before interest, tax, depreciation and amortisation declined to 39.34 crore from 160.25 crore. The company said the prior-year figures included activities that are no longer within its scope following the demerger of two businesses. The comparison therefore reflects a narrower business scope as well as a change in performance, and on its own does not provide a like-for-like measure of the remaining business.
The share price was lower earlier in the session, touching 269.00 rupees, down 2.20%, at 13:14 India time. It then trimmed its losses to 1.39% in the subsequent update, without changing its negative direction during trading. The market move places the November 18 session in the context of the results announcement, but the available figures do not attribute the share decline to a specific cause. Nor do they establish a link between the stock's performance and Indian inflation or trade data. The company's results and the reorganisation of its businesses remain the main company-specific elements in the disclosures available for the period.
In the first half of FY27, India Glycols reported standalone operating revenue of 712.82 crore rupees, compared with 4,913.74 crore in the year-earlier period. Earnings before interest, tax, depreciation and amortisation were 79.55 crore, versus 309.51 crore, while profit after tax was 23.59 crore, down from 106.79 crore. The company said the period's results reflected continuing operations after the demerger. The figures point to broad declines across all three measures year on year, with the comparison still affected by differences in the activities included in results for the two periods. The first-half figures offer a broader time frame than the quarter alone, but carry the same limitation related to business scope.
The reorganisation involved demerging the bio-spirits and biofuels business and the bio-pharma business into IGL Spirits Limited and Ennature Bio Pharma Limited. India Glycols retains specialty bio-based products, sustainable chemicals, performance chemicals and gases. Under this arrangement, revenue and earnings for the current quarter relate to continuing operations under the new structure, while the prior-year comparison includes businesses that were demerged. The impact of the difference in scope is clear in the gap between the two quarters' revenue figures, although the figures provided do not detail each demerged business's contribution to the prior-year comparison. The company said the previous year's figures should be read with the demerger of the bio-spirits and biofuels and bio-pharma businesses in mind. This caveat remains central to assessing the performance of the business retained by the company.
In the broader economic backdrop, India's consumer price inflation was 6.09% in October 2026, up from 5.54% in September, according to government data cited by Reuters. The reading was above the Reuters poll forecast of 5.93%, while food inflation rose to 8.94% from 7.74%. The Reserve Bank of India targets medium-term inflation of 4%, within a tolerance band of 2% to 6%. Reuters quoted economists as saying inflation above the band’s upper limit could support another rate increase in December, while ICRA forecast an average of 6.2% in the third quarter of FY27, compared with the central bank's forecast of 6.0%. These figures indicate the economic and monetary-policy environment in India, with no evidence linking them to India Glycols' share movement during the session.
The company had scheduled an investor call on its second-quarter and first-half FY27 results for November 18, 2026, at 16:00 India time, with the chief executive and chief financial officer participating. The call follows publication of the official results and gives management an opportunity to present the two periods' figures in the context of the business reorganisation. The published results focus on operating revenue, EBITDA and profit after tax from continuing operations. The interpretation of the year-on-year comparison also depends on identifying the businesses transferred to the two new companies. The call is the next scheduled event in the company's disclosures on these results.